Reference
Kunimasa K, et al. Dacomitinib overcomes afatinib-refractory carcinomatous meningitis in a lung cancer patient harbouring EGFR Ex.19 deletion and G724S mutation; a case report. Investigational New Drugs 40: 1137-1140, No. 5, Oct 2022. Available from: URL: http://doi.org/10.1007/s10637-022-01264-0
Rights and permissions
About this article
Cite this article
Afatinib/gefitinib. Reactions Weekly 1942, 18 (2023). https://doi.org/10.1007/s40278-023-32627-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-32627-6